Analyst Ratings for Amgen (AMGN)
AMGN Rating Summary
AMGN Price Target Summary
- Highest: $130.00 (Goldman Sachs)
- Lowest: $58.00 (BMO Capital)
- Average: $88.27
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$88.27 (-11%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/1/2013 | Goldman Sachs | Upgrade | Conviction Buy (Neutral) |
130.00 (100.00) |
104.21 | 99.18 | -4.83% | Details |
| 4/24/2013 | Piper Jaffray | Downgrade | Neutral (Overweight) |
N/A (N/A) |
112.76 | 99.18 | -12.04% | Details |
| 2/11/2013 | William Blair | Downgrade | Market Perform (Outperform) |
N/A (N/A) |
86.77 | 99.18 | 14.3% | Details |
| 1/25/2013 | Argus | Upgrade | Buy (Hold) |
N/A (N/A) |
82.62 | 99.18 | 20.04% | Details |
| 1/22/2013 | Credit Suisse | Downgrade | Neutral (Outperform) |
N/A (N/A) |
82.08 | 99.18 | 20.83% | Details |
| 11/9/2012 | Guggenheim | New Coverage | Neutral (N/A) |
93.00 (N/A) |
84.74 | 99.18 | 17.04% | Details |
| 10/22/2012 | Deutsche Bank » Updated 6/12/2013 |
Upgrade | Buy (Hold) |
115.00 (N/A) |
87.16 | 99.18 | 13.79% | Details |
| 9/27/2012 | Brean Capital | New Coverage | Buy (N/A) |
96.00 (N/A) |
83.46 | 99.18 | 18.84% | Details |
| 9/12/2012 | Baird | Downgrade | Neutral (Outperform) |
84.00 (83.00) |
83.94 | 99.18 | 18.16% | Details |
| 9/10/2012 | UBS | Upgrade | Buy (Neutral) |
N/A (N/A) |
83.96 | 99.18 | 18.13% | Details |
| 8/7/2012 | Lazard Capital | Upgrade | Buy (Sell) |
101.00 (N/A) |
82.43 | 99.18 | 20.32% | Details |
| 3/15/2012 | Stifel Nicolaus | New Coverage | Hold (N/A) |
N/A (N/A) |
68.26 | 99.18 | 45.3% | Details |
| 3/6/2012 | Bernstein | Downgrade | Market Perform (N/A) |
76.00 (N/A) |
67.23 | 99.18 | 47.52% | Details |
| 2/10/2012 | Morgan Stanley | New Coverage | Equalweight (N/A) |
N/A (N/A) |
66.84 | 99.18 | 48.38% | Details |
| 2/9/2012 | Oppenheimer » Updated 11/26/2012 |
Downgrade | Perform (N/A) |
89.00 (N/A) |
68.06 | 99.18 | 45.72% | Details |
